These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 12431491)
1. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491 [TBL] [Abstract][Full Text] [Related]
2. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229 [TBL] [Abstract][Full Text] [Related]
3. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation. Diujvestijn AM; Derhaag JG; van Breda Vriesman PJ Transpl Int; 2000; 13(5):363-71. PubMed ID: 11052273 [TBL] [Abstract][Full Text] [Related]
4. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [TBL] [Abstract][Full Text] [Related]
5. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337 [TBL] [Abstract][Full Text] [Related]
6. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533 [TBL] [Abstract][Full Text] [Related]
7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
8. Involvement of antibody-dependent apoptosis in graft rejection. Plissonnier D; Henaff M; Poncet P; Paris E; Tron F; Thuillez C; Michel JB Transplantation; 2000 Jun; 69(12):2601-8. PubMed ID: 10910283 [TBL] [Abstract][Full Text] [Related]
9. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts. Dong C; Granville DJ; Tuffnel CE; Kenyon J; English D; Wilson JE; McManus BM Lab Invest; 1999 Dec; 79(12):1643-53. PubMed ID: 10616213 [TBL] [Abstract][Full Text] [Related]
10. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats. Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523 [TBL] [Abstract][Full Text] [Related]
11. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053 [TBL] [Abstract][Full Text] [Related]
12. Chronic renal allograft rejection: the significance of non-MHC alloantigens. Duijvestijn A; Vlek L; Duistermaat L; van Rie H; van Breda Vriesman P Transpl Int; 1992; 5 Suppl 1():S639-44. PubMed ID: 14621897 [TBL] [Abstract][Full Text] [Related]
13. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival. Wasowska B; Baldwin WM; Sanfilippo F Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737 [TBL] [Abstract][Full Text] [Related]
14. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Vella JP; Magee C; Vos L; Womer K; Rennke H; Carpenter CB; Hancock W; Sayegh MH Transplantation; 1999 Jun; 67(12):1523-32. PubMed ID: 10401758 [TBL] [Abstract][Full Text] [Related]
16. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711 [TBL] [Abstract][Full Text] [Related]
17. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion. Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043 [TBL] [Abstract][Full Text] [Related]
18. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Joosten SA; van Dixhoorn MG; Borrias MC; Benediktsson H; van Veelen PA; van Kooten C; Paul LC Am J Pathol; 2002 Apr; 160(4):1301-10. PubMed ID: 11943715 [TBL] [Abstract][Full Text] [Related]
19. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187 [TBL] [Abstract][Full Text] [Related]
20. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Adams DH; Russell ME; Hancock WW; Sayegh MH; Wyner LR; Karnovsky MJ Immunol Rev; 1993 Aug; 134():5-19. PubMed ID: 8225375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]